Sharechat Logo

Ebos profit steady

By Phil Boeyen, ShareChat Business News Editor

Wednesday 23rd August 2000

Text too small?
Listed healthcare distributor Ebos says its latest $4.238 million profit result shows the merits of its philosophy to expand its revenue base.

The tax paid profit figure is a slight dip on last year's $4.250 million, but the company says it has managed the similar result in spite of a weak dollar and challenging trading conditions.

Ebos says the benefit of new initiatives such as the acquisition of 50% of Health Support Limited, and the full acquisition of Maygar Medical (Brisbane) and Medic Corporation provide a very good foundation for strong profit growth for the future.

The directors says they are pleased with progress in all businesses, not withstanding the currency impact in an industry that cannot absorb the full flow on effects of price adjustments in a short time frame.

Ebos is setting a final dividend 6.5 cents. Last year's final dividend was 9 cents per share.

Ebos shares closed 21 cents down on Wednesday at $3.55.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Ebos still hungry for acquisitions after $1.1 bln Symbion deal, Waller says
Ebos meets prospectus forecast with 5.5 percent gain in FY profit
Ebos shareholders approve $1.1 billion purchase of Symbion
Ebos grabs scale with $1.1 bln purchase of Aussie pharma distributor Symbion
Ebos kicks tyres on potential acquisitions
Ebos lifts profit by 19%, targets growth in animal health
Ebos funding line smaller than previously flagged at $135 mln
Ebos Group
Ebos backs off British purchase, evaluates "significant" Australasian asset
Ebos reports higher profit, looks for acquisitions

IRG See IRG research reports